Last reviewed · How we verify
NCT05808699
Camera Qualification Study
trial testing handheld fundus camera in Diabetic Retinopathy in 626 participants. Participants enrolled and being followed up; not accepting new ones.
30 November 2023
Quick facts
| Lead sponsor | Digital Diagnostics, Inc. |
|---|---|
| Status | Active, enrolled |
| Study type | OBSERVATIONAL |
| Enrollment | 626 |
| Start date | 3 March 2023 |
| Primary completion | 30 November 2023 |
| Estimated completion | 30 January 2025 |
| Sites | 9 locations across United States |
Drugs / interventions tested
- handheld fundus camera
Conditions studied
- Diabetic Retinopathy — all drugs for Diabetic Retinopathy →
Sponsor
Digital Diagnostics, Inc.
Who can join
22 and older, any sex, with Diabetic Retinopathy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A multi-center study to evaluate the performance of an automated device for the detection of diabetic retinopathy with the use of an additional fundus camera with IDx-DR.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Mitigation of AI adoption bias through an improved autonomous AI system for diabetic retinal disease.
Abràmoff MD, Lavin PT, Jakubowski JR, Blodi BA, et al · · 2024 · cited 6× · PMID 39702673 · DOI 10.1038/s41746-024-01389-x
Verify or expand the search:
- PubMed search for NCT05808699
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetic Retinopathy
Currently open trials in the same condition.
- NCT07255326 — Effect of Omega-3 Fatty Acids on Eye Blood Vessels in Type 1 Diabetes · NA · recruiting
- NCT06782997 — Performance of the Electroretinogram, Performed and Interpreted by an Advanced Practice Nurse, in the Screening for Diab · recruiting
- NCT07002372 — Effect of Video Viewing on Intravitreal Injection Experience · NA · recruiting
- NCT06713720 — Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy · NA · recruiting
- NCT06892353 — AI-Powered DIY Screening System for Diabetic Retinopathy · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05808699 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Digital Diagnostics, Inc.
- Last refreshed: 22 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05808699.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing